Zach Berman MD
@ZTBerman
Followers
265
Following
107
Media
38
Statuses
158
Meliorist and Monozukuri , #Bernedoodle Dad, Interventional Oncologist @UCSDHealth
San Diego, CA
Joined January 2012
Glad to see our MultiD collaboration gaining traction. #PASTIME - @ucsd_ir @UCSD_ObGyn @rupalparikh90 @SIRspecialists.
Placenta Accreta Spectrum (PAS) is a high-risk condition requiring coordinated care. This SIR MSC WIR infographic outlines the PASTIME approach as an IR model within a multidisciplinary framework #WIRSIR
0
0
2
🔥Our Recent Publication Highlighting the Importance of 💉Biopsy for HCC🔥 Even in the era of LI-RADS molecular profiling is/will be important for deciding 💊. . @ucsd_ir @UCSDRadRes @SIO_Central @_backtable @SIRspecialists @BeauToskichMD.
0
1
6
Further confirmation of the high ORR and DoR of TARE for HCC. I suspect today marks the death of BSA and the beginning of the era of personalized dosimetry.
We're proud to announce that SIR-Spheres® is now the only FDA approved radioembolization therapy for both unresectable HCC & colorectal cancer liver metastases in the U.S. Read the full announcement: SIR-Spheres® Safety Info:
0
2
6
RT @CVIR_Journal: Editor's Choice! 📖.Read this interesting commentary on the paper of Tahir et al, underlying the benefits of personalized….
0
3
0
RT @_backtableONC: In this discussion, the multidisciplinary panel focuses on a case of a non-cirrhotic patient with a solitary #HCC lesion….
0
2
0
Coming off of a great SIR, presenting our robotic ablation experience, here is a nice robotic MWA case for two obliquely placed probes covering an irregular CRC met with margin confirmation. @ucsd_ir @SIRspecialists @SIO_Central @QuantumSurgical @_backtable @_backtableONC
0
3
11
RT @_backtable: Is Y90 Dosimetry Adequately Taught During IR Fellowship?-- IRs reflect on their prior education in dosimetry and share thei….
0
5
0
RT @SIRspecialists: Congratulations to our Best Traditional Poster and the Best Educational Exhibit presentation winners! Your research and….
0
3
0
I am incredibly interested to see the results! Nice work NW team. Going to be a great session.
Preview one of SIR's Abstracts of the Year! Hear from @SamMouli on the Frontier Study: Preliminary Results of Safety and Feasibility of Yttrium-90 TheraSphere in Recurrent Glioblastoma. Read here: #TheraSphereGBM #Y90 #FRONTIERstudy #SIR2025
0
0
7
RT @mskbradiologist: Congrats to our new #radres! Welcome to @UCSDRadRes and @UCSDImaging!!! Thank you to our PD's and admins for your tire….
0
7
0
RT @ucsd_ir: Congratulations to all on the match! We can't wait to meet our new UCSD IR and DR residents!.#MatchDay2025 .
0
6
0
RT @BeauToskichMD: #Y90 radiation segmentectomy is now a recommended ablative modality by the AASLD for unresectable BCLC A #HCC or as a br….
0
22
0
Had a great time making this and learned a ton! Def recommend a listen.
A recent hepatocellular carcinoma (HCC) @_backtableONC episode tackles key cases, from multifocal HCC to post-transplant metastasis. Watch now with MCC's @ZTBerman & Dr. Adam Burgoyne: 🎙️
0
2
7
RT @_backtableONC: Here's a CASE-BASED episode with our #HCC Tumor Board, covering diff scenarios & how to think thru each one: https://t.c….
0
3
0
🔥Hot off the press🔥 Voxel-Based tumor dose matters for HCC - particularly D95. Now to explore this for big tumors?🤔 @ucsd_ir @uclaVIR @bsc_io @SirtexMedical @SIO_Central @SIRspecialists @_backtable
1
3
15
RT @_backtable: Today on BackTable: @ZTBerman hosts an all-star panel of IRs who provide insights on their journeys to building their inter….
0
4
0
RT @BeauToskichMD: No MAA for hepatocellular carcinoma <3 cm treated with Y90 radiation segmentectomy expedites care, reduces the number of….
0
4
0
RT @_backtable: Today on @_backtableONC : We explore the "grey zone" of treatment goals for #HCC patients with intermediate-stage/BCLC-B di….
0
4
0
RT @SirtexMedical: We had an incredible time at the @SIO_Central Annual Scientific Meeting! Thank you to those who stopped by our booth, at….
0
1
0
RT @UCSDCancer: Looking for a multidisciplinary podcast for healthcare professionals involved in cancer care? Check out @_backtableONC! 🙌….
0
2
0